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Background. Depressed mood following an acute coronary syndrome (ACS) is a risk factor for future cardiac
morbidity. Hypothalamic–pituitary–adrenal (HPA) axis dysregulation is associated with depression, and may be a
process through which depressive symptoms inﬂuence later cardiac health. Additionally, a history of depression
predicts depressive symptoms in the weeks following ACS. The purpose of this study was to determine whether a
history of depression and/or current depression are associated with the HPA axis dysregulation following ACS.
Method. A total of 152 cardiac patients completed a structured diagnostic interview, a standardized depression
questionnaire and a cortisol proﬁle over the day, 3 weeks after an ACS. Cortisol was analysed using : the cortisol
awakening response (CAR), total cortisol output estimated using the area under the curve method, and the slope of
cortisol decline over the day.
Results. Total cortisol output was positively associated with history of depression, after adjustment for age, gender,
marital status, ethnicity, smoking status, body mass index (BMI), Global Registry of Acute Cardiac Events (GRACE)
risk score, days in hospital, medication with statins and antiplatelet compounds, and current depression score. Men
with clinically diagnosed depression after ACS showed a blunted CAR, but the CAR was not related to a history of
depression.
Conclusions. Patients with a history of depression showed increased total cortisol output, but this is unlikely to be
responsible for associations between depression after ACS and later cardiac morbidity. However, the blunted CAR in
patients with severe depression following ACS indicates that HPA dysregulation is present.
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Introduction
The growing evidence that depression in patients
who have survived an acute coronary syndrome
(ACS) is a risk factor for future cardiovascular mor-
bidity (Meijer et al. 2011) has stimulated eﬀorts to
understand mediating biobehavioural processes.
Inﬂammation, autonomic dysregulation, endothelial
dysfunction and failure to adhere to medication and
lifestyle advice have been implicated (de Jonge et al.
2010 ; Poole et al. 2011). Another candidate is hypo-
thalamic–pituitary–adrenal (HPA) dysregulation,
which may lead to failure to limit inﬂammatory ac-
tivity (Nijm & Jonasson, 2009) while stimulating other
mechanisms contributing to coronary heart disease
(CHD) (Brotman et al. 2007). Vogelzangs et al. (2010)
recently reported that elevated 24-h cortisol con-
centrations in urine were associated with increased
risk of cardiovascular mortality over the next 6 years,
independently of covariates, whereas a ﬂatter slope
of salivary cortisol decline over the day predicted
cardiovascular mortality in the Whitehall II study
(Kumari et al. 2011). Subclinical atherosclerosis de-
ﬁned by coronary artery calciﬁcation or carotid plaque
has also been associated with heightened cortisol
stress responses (Hamer et al. 2010), ﬂatter cortisol
proﬁles over the day (Matthews et al. 2006) and greater
overall cortisol output over the day (Dekker et al.
2008). An elevated cortisol awakening response (CAR)
predicted progression of carotid intima media thick-
ness over a 4-year period in women (Eller et al. 2005),
but the CAR was blunted in a small study of hyper-
tensive versus non-hypertensive men (Wirtz et al.
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2007). In patients with diabetes, elevated morning
cortisol was associated with the presence of CHD
(Reynolds et al. 2010a), whereas cortisol levels on ad-
mission to hospital with ACS have been related to
both unfavourable (Bain et al. 1992 ; Tenerz et al. 2003)
and favourable (Fantidis, 2010 ; Reynolds et al. 2010b)
prognoses.
Disturbed HPA activity and modiﬁcations in cor-
tisol output have also been implicated in depression
(Belmaker & Agam, 2008; Pariante & Lightman, 2008).
However, studies associating cortisol with depression
in cardiac patients have not identiﬁed consistent re-
lationships. An evaluation of urinary cortisol in the
Heart and Soul Study showed positive associations
with depression in chronic CHD patients (Otte et al.
2004) but other studies have found that elevated
morning cortisol (von Kanel et al. 2008) or ﬂatter di-
urnal proﬁles (Bhattacharyya et al. 2008) were related
to depression. In a previous study we found no as-
sociation between depressive symptoms and cortisol
output over the day measured 4 months after hos-
pitalization with an ACS (Molloy et al. 2008). One
important issue that has not been consistently taken
into account is the patient’s history of depression.
Depressive symptoms in the period following ACS are
predicted by previous history of depressive illness
(Lesperance et al. 1996 ; Spijkerman et al. 2005 ; Martens
et al. 2008). It might be the case that associations
between cortisol output following ACS and de-
pression are secondary to the inﬂuence of depression
history. The aim of this study was therefore to deter-
mine whether a history of depression and current de-
pression are associated with the proﬁle of cortisol over
the day measured 3 weeks after an ACS.
Method
Study population
The participants were 222 patients admitted with ACS
to St George’s Hospital in South London between June
2007 and October 2008 as part of a larger study relating
biological and emotional factors in acute cardiac
patients (Steptoe et al. 2011a, b). Patients were included
if they fulﬁlled the following criteria : a diagnosis
of ACS based on the presence of chest pain plus
veriﬁcation by diagnostic electrocardiographic (ECG)
changes, troponin T or troponin I o99th percentile
of the upper reference limit and/or a creatine
kinase measurement more than twice the upper range
of normal for the measuring laboratory. Additional
inclusion criteria were age of 18 years or over, absence
of co-morbid conditions that might inﬂuence either
symptom presentation or mood, other conditions
that might cause troponin positivity, and ability to
complete interviews and questionnaires in English.
The study was approved by the Wandsworth Re-
search Ethics Committee (Institutional Review Board),
and written consent was obtained.
Clinical and sociodemographic measures
Information was obtained from medical notes about
cardiovascular history, clinical factors during
admission and management. Admission ECGs were
reviewed and scrutinized for presentation as ST elev-
ation myocardial infarction (STEMI) or non-STEMI/
unstable angina. We computed the composite risk
index based on the algorithm developed in the Global
Registry of Acute Cardiac Events (GRACE) study
(Eagle et al. 2004) and validated in independent
studies (Alter et al. 2006). This uses nine criteria (age,
congestive heart failure, history of MI, systolic blood
pressure and heart rate on admission, ST segment
depression, initial serum creatinine, elevated cardiac
enzymes and in-hospital percutaneous coronary inter-
vention) to deﬁne risk of 6-month post-discharge
death applicable to all types of ACS. The number of
days spent in hospital was included as an additional
indicator of clinical status. This variable showed a
skewed distribution so was log transformed before
analysis.
Socio-economic status (SES) was assessed using a
social deprivation index based on three criteria : living
in a crowded household (deﬁned as one or more
people to a room), renting as opposed to owning a
home, and not having use of a motor vehicle (car or
van) (Strike et al. 2006). Patients were classiﬁed as low
deprived (negative on all items), medium deprived
(one positive) and high deprived (2–3 positive). In-
formation concerning marital status, ethnicity and
smoking was obtained by interview, and height and
weight were recorded on admission for the compu-
tation of body mass index (BMI).
Assessment of depression
Patients were assessed in their homes at an average
21.6¡8.5 days following admission to hospital. The
assessment included the Depression Interview and
Structured Hamilton (DISH; Freedland et al. 2002),
which was developed for the Enhancing Recovery in
Coronary Heart Disease (ENRICHD) study. The DISH
generates a clinical diagnosis of major and minor
depression based on DSM-IV. All researchers had
been trained in the interview technique. In view of the
relatively small numbers in the study, these categories
were combined for analysis. Lifetime history of clinical
depression was obtained from the DISH. The Beck
Depression Inventory (BDI ; Beck et al. 1988) was also
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administered as part of this interview. This measure
consists of 21 items rated on a scale of 0–3, so maxi-
mum scores can range from 0 to 63. The Cronbach a in
this sample was 0.86.
Cortisol sampling
Salivary sampling with salivettes (Sarstedt, UK) was
explained and undertaken during the interview at the
patient’s home. Cortisol sampling was undertaken
during the next few days after the interview at the
patient’s home. Patients were asked to hold the cotton
dental roll in their mouths for 2 min at six times : im-
mediately after waking, 30 min later, 10:00–10:30 h,
14:00–14:30 h, 19:00–19:30 h, and then just before bed-
time. Patients also recorded the exact time of sample
collection and the time of waking. They were in-
structed to avoid caﬀeine and acidic drinks, smoking,
tooth brushing, eating and drinking for 15 min before
collecting saliva. Salivettes were stored in domestic
refrigerators before posting them back to the labora-
tory. Patients who did not return their samples within
2 weeks were sent reminders and replacement saliv-
ettes if necessary. Saliva samples were sent to the
Technical University Dresden for the analysis of
cortisol by chemiluminescence immunoassay (CLIA;
IBL-Hamburg, Germany). Inter- and intra-assay co-
eﬃcients of variation were<8%.
Statistical analysis
Of the 222 patients interviewed 3 weeks after ACS,
saliva samples were returned by 160 (72%), and com-
plete usable cortisol data were obtained from 152.
These individuals were included in the primary
analyses. Seven people were not asked to collect saliva
for dental or other reasons ; the majority of non-
respondents agreed verbally to collect the samples
yet failed to do so. The patients who did and did
not provide cortisol data did not diﬀer in gender, eth-
nicity, marital status, BMI, type of ACS, history of MI,
number of days spent in hospital, or in medication
at the time of interview. However, the patients who
did not complete cortisol assessments were signiﬁ-
cantly younger (mean age=55.43, S.D.=12.29 years
versus mean age=61.70, S.D.=10.94 years, p<0.001),
were more socially deprived (p<0.001), more likely to
be smokers (52.8% versus 30.9%, p=0.002) and had
lower GRACE risk scores (mean=84.40, S.D.=27.21
versus mean=95.05, S.D.=25.43, p=0.005). They were
also more depressed on the BDI on average than those
whose cortisol was analysed (mean=8.34, S.D.=9.00
versus mean=5.90, S.D.=5.12, p=0.011), but did not
diﬀer in history of depression (p=0.21).
Cortisol output was analysed using three measures :
the cortisol awakening response (CAR), computed
as the diﬀerence between measures taken on waking
and 30 min later, total output over the day, estimated
using the area under the curve method with respect
to ground (Pruessner et al. 2003a), and the slope of
cortisol decline over the day, computed as the re-
duction in cortisol per hour using regression methods.
The slope measure excluded the 30-min post-waking
sample, as is common in this literature. The CAR is
crucially dependent on the waking cortisol sample
being obtained without marked delays after waking
because postponement can reduce the magnitude of
the awakening response (Chida & Steptoe, 2009).
Based on analyses comparing self-report and objec-
tively measured waking (Dockray et al. 2008), we
excluded individuals from the CAR analyses if the
waking sample was delayed >15 min after reported
waking times. Seven individuals were excluded from
the analyses on this basis. The CAR values were nor-
mally distributed, but the total output over the day
and cortisol slopes were log transformed before
analysis.
Comparisons of background factors between
patients with and without a history of depression
were carried out with t tests for continuous and x2 tests
for categorical variables. Associations between de-
pression following ACS, history of depression, and
cortisol were carried out using multivariable re-
gression on the three cortisol measures. Factors related
to the severity of cardiac disease (GRACE score,
number of days spent in hospital) and other variables
that might inﬂuence depression or cortisol (age,
gender, ethnicity, social deprivation, marital status,
BMI, smoking status) were included as covariates in
the models, as were medication with statins and anti-
platelet preparations. The analyses of the CAR in-
cluded time of the ﬁrst sample as an additional
covariate because this has previously been related to
the magnitude of responses (Edwards et al. 2001).
There were no indications of multicollinearity in
the dataset as determined by the variance inﬂation
factor. Additionally, cortisol levels in patients with
and without a history of depression and with and
without diagnosed depression following ACS were
compared by analysis of covariance, with the variables
listed above included as covariates. The results are
presented as means¡standard deviations.
Results
Participant characteristics are detailed in Table 1,
where it can be seen that the majority were white men
who experienced a STEMI. A history of depression
was reported by 27%. A higher proportion of patients
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with a history of depression were women (p=0.050)
and tended to be younger (p=0.090). Patients with
a history of depression were more often smokers
(p=0.005) and had a lower BMI (p=0.024). There
were, however, no other diﬀerences in clinical
characteristics or medication. As expected, scores on
the BDI obtained 3 weeks after ACS were signiﬁcantly
higher among patients with a history of depression
(p=0.020). The proportion of patients with major and
minor depression according to the DISH was 19.4%,
with a greater percentage among patients with a
positive than a negative history of depression (25.8%
v. 16.6%). However, because of attrition of patients
with greater depression scores from cortisol sampling,
the proportion with DISH diagnosed depression in-
cluded in these analyses was 16.2%, comprising 21
men (16.7%) but only two women (12.5%). Mean BDI
scores 3 weeks after ACS were substantially higher in
the diagnosed depressed compared with non-
depressed patients (mean=13.88¡9.06 and 4.92¡4.18
respectively, p<0.001). The waking cortisol sample
was obtained at 07 :18 h¡64 min on average, with
the 30-min sample taken at 07 :51 h¡66 min. The four
remaining samples were obtained at 10 :09¡30,
14 :07¡30, 19:06¡36 and 22:37 h¡50 min, indicating
good adherence to the protocol. The CAR (n=139)
averaged 4.28¡9.12 nmol/l.
The CAR was not related to depressed mood fol-
lowing ACS assessed with the BDI. However, men
who were diagnosed with depression on the DISH had
smaller CARs than the remainder, after adjusting
for age, ethnicity, marital status, social deprivation,
smoking status, BMI, GRACE risk score, days in hos-
pital, medication with statins and antiplatelet com-
pounds, history of depression, and time of the ﬁrst
sample (p=0.038). This eﬀect is shown in Fig. 1, where
it is evident that the two groups did not diﬀer in cor-
tisol output on waking, but that the depressed patients
showed no rise in cortisol after 30 min. The mean CAR
adjusted for covariates was 0.41¡6.81 nmol/l in the
depressed compared with 6.03¡9.05 nmol/l in the
non-depressed participants. There was no diﬀerence
in time of waking or SES between the groups. Thus,
depression following ACS was associated with a
blunted CAR among male cardiac patients.
The regression model on total cortisol output is
summarized in Table 2. Total cortisol output was
positively associated with history of depression
Table 1. Characteristics of the patients with and without a history of depression
Positive history
of depression
(n=41)
No history of
depression
(n=111) p
Age (years), mean (S.D.) 59.22 (10.57) 62.61 (10.99) 0.090
Men/women, n (%) 32/9 (78/22) 101/10 (91/9) 0.050
Ethnic minority, n (%) 9 (22) 13 (11.7) 0.12
Married, n (%) 29 (70.7) 82 (73.9) 0.69
Social deprivation, n (%)
Low 29 (72.5) 87 (79.8) 0.44
Medium 9 (22.5) 17 (15.6)
High 2 (5.0) 5 (4.6)
BMI (kg/m2), mean (S.D.) 25.97 (3.29) 27.69 (4.29) 0.024
Smoker, n (%) 20 (48.8) 27 (24.3) 0.005
Diagnosis, n (%)
STEMI 35 (85.4) 102 (91.9) 0.23
Previous MI 2 (4.9) 17 (15.3) 0.10
GRACE score, mean (S.D.) 88.71 (23.92) 97.40 (25.69) 0.061
Days in hospital, mean (S.D.) 5.15 (2.60) 5.56 (3.95) 0.54
Medication, n (%)
Statins 39 (95.1) 105 (96.3) 0.66
Beta-blockers 32 (78.0) 88 (80.7) 0.82
RAS medication 38 (92.7) 94 (86.2) 0.40
Anti-platelet 41 (100) 107 (98.2) 1.00
Depression (BDI score), mean (S.D.) 7.48 (5.39) 5.31 (4.91) 0.020
BMI, Body mass index ; STEMI, ST elevation myocardial infarction ; GRACE,
Global Registry of Acute Cardiac Events ; RAS, renin–angiotensin system; BDI, Beck
Depression Inventory ; S.D., standard deviation.
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[B=0.192, 95% conﬁdence interval (CI) 0.040–0.345,
p=0.014], after adjustment for age, gender, marital
status, social deprivation, ethnicity, smoking status,
BMI, GRACE risk score, days in hospital, medication
with statins and antiplatelet compounds, and current
BDI score. Current BDI score was not associated with
cortisol output. The association between history of
depression and cortisol output is illustrated in Fig. 2,
where it can be seen that cortisol levels were similar
on waking in the two groups. Subsequently, cortisol
levels were moderately elevated throughout the day
in patients with a positive history of depression, con-
verging again at bedtime. Apart from history of de-
pression, the only other variable independently to
predict cortisol output over the day was medication
with statins. Additional analyses (not detailed here)
comparing extreme BDI groups, assessing cognitive
and somatic symptoms of depression as deﬁned by de
Jonge et al. (2006), or comparing patients with major or
minor depression according to the DISH, did not show
any further links with cortisol output. There was no
association between cortisol slope over the day and
any of the factors mentioned above (see Table 2).
Discussion
This study evaluated cortisol output over the day in
patients who had recently survived an ACS, in order
to investigate the relevance of HPA dysfunctioning
to the association between post-ACS depression and
future cardiac morbidity. Total cortisol output over
the day was not related to depression assessed 3 weeks
after an ACS. It was, however, elevated in patients
with a history of depression, and this association was
independent of demographic factors, markers of the
clinical severity of the cardiac event, medication, and
current depressed mood. Additionally, male patients
who were diagnosed using a structured interview
with major or minor depression at 3 weeks after their
ACS showed a blunted CAR that was again indepen-
dent of covariates.
At least 50% of patients with a major depressive
disorder experience one or more recurrences in the
future (Mueller et al. 1999). Predictors of recurrent
depression include the number of previous episodes,
persisting subsyndromal symptomatology and stress
exposure, and it has been suggested that disturbances
of HPA regulation may also contribute (O’Toole et al.
1997 ; Appelhof et al. 2006). The relationship between
HPA functioning and depression is complex, and dis-
turbances in cortisol responses to stress, hippocampal
control of the HPA and glucocorticoid receptor ex-
pression have been implicated (Pariante & Lightman,
2008 ; Snyder et al. 2011 ; Stetler & Miller, 2011). The
experience of a severe cardiac event such as an ACS is
a strong emotional stressor, but the fact that elevated
cortisol output was not related to depressed mood or
diagnosed depression 3 weeks after an ACS suggests
that the phenomenon is not speciﬁcally associated
with experience of ACS. Nonetheless, the observation
that these individuals have raised cortisol output over
the day may increase their risk of cardiac sequelae
through the impact of HPA function on inﬂammatory
responses, endothelial dysfunction and insulin resist-
ance (Girod & Brotman, 2004 ; Broadley et al. 2005).
Interpretation of the association between de-
pression following an ACS and a reduced CAR must
be made cautiously, in light of the fact that eﬀects
emerged in analyses based on the DISH clinical inter-
view rather than continuous scores on the BDI. It is,
however, interesting that the more severe indications
of current depression identiﬁed in the clinical inter-
view were associated with the CAR. The proportion of
individuals diagnosed as depressed was comparable
to those reported in other studies (Thombs et al. 2008).
Some studies in populations without CHD have
shown heightened CARs in more depressed in-
dividuals (Bhagwagar et al. 2005 ; Pruessner et al.
2003b), whereas others have described diminished
responses (Stetler & Miller, 2005). In two studies with
diﬀerent groups of cardiac patients, we found no re-
lationship between depressive symptoms measured
with the BDI and the CAR (Bhattacharyya et al. 2008 ;
Molloy et al. 2008). The results in this study suggest
that disturbances of cortisol output early in the day
are only associated with more severe depression as
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Fig. 1.Mean salivary cortisol on waking and 30 min later in
male patients with (broken line, triangle) and without (solid
line, square) current major or minor depression diagnosed
using the Depression Interview and Structured Hamilton
(DISH). Values are adjusted for age, marital status, social
deprivation, ethnicity, smoking status, body mass index
(BMI), Global Registry of Acute Cardiac Events (GRACE)
risk score, days in hospital, medication with statins and
antiplatelet compounds, history of depression and time of
the ﬁrst sample. Error bars are standard errors of the mean.
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identiﬁed by clinical interview, rather than depressive
symptoms as a continuous variable. We did not test
eﬀects in women because only two female patients
who completed satisfactory early day cortisol assess-
ments were diagnosed with depression on the clinical
interview.
Another striking feature of the results is the rela-
tively small CAR recorded even in non-depressed
ACS patients. We did not test a healthy comparison
group, but previous studies from our laboratory of
individuals within the same age range have shown
mean CARs in the range 6–10 nmol/l, compared with
4.28 nmol/l here (Kunz-Ebrecht et al. 2004 ; Wright &
Steptoe, 2005). Further studies are clearly required to
explore the inconsistencies in these results. However,
the complete absence of a CAR may indicate dis-
turbances of HPA regulation that are potentially rel-
evant to future cardiovascular risk.
A relevant factor to the interpretation of these ﬁnd-
ings was the low response rate (72%) for completion of
cortisol assessments. Patients who failed to provide
cortisol samples were younger, more likely to be
socially deprived, and had suﬀered a less severe ACS.
They were also more depressed at the time of the
3-week interview. The reasons why they did not
return saliva samples are not certain. As these patients
were more socio-economically deprived and had a less
severe cardiac event than the remainder, they may
have returned to work more promptly and therefore
found it more diﬃcult to incorporate the saliva
sampling into their everyday lives. Alternatively,
their greater depression may have made them less
compliant to the demands of the study. Importantly,
they did not diﬀer from the remainder in their history
of depression, so the response rate is unlikely to have
aﬀected the association between depression history
and cortisol. However, their greater depression at the
time of the 3-week interview may have compromised
tests of associations between current depressed mood
and total cortisol output. We consider this unlikely,
because analyses of more extreme current depression
groups or comparisons of individuals with and with-
out clinical depression at the time of interview did not
indicate stronger relationships with total cortisol out-
put over the day.
Table 2. Regressions on cortisol output
Total cortisol output Cortisol awakening response (CAR) Cortisol slope
B (95% CI) p B (95% CI) p B (95% CI) p
Age 0.010 (x0.001 to 0.021) 0.082 x0.228 (x0.624 to 0.169) 0.26 x0.000 (x0.001 to 0.000) 0.64
Gendera x0.105 (x0.319 to 0.110) 0.34 3.94 (x3.15 to 11.03) 0.27 x0.006 (x0.012 to 0.000) 0.053
Ethnicityb x0.151 (x0.341 to 0.040) 0.12 7.04 (0.238 to 13.84) 0.043 0.000 (x0.006 to 0.005) 0.85
Marital statusc 0.041 (x0.117 to 0.199) 0.61 3.36 (x2.08 to 8.81) 0.22 0.003 (x0.001 to 0.008) 0.16
Social deprivation 0.075 (x0.051 to 0.201) 0.24 1.37 (x3.35 to 6.08) 0.57 x0.001 (x0.005 to 0.003) 0.58
Smokingd x0.004 (x0.154 to 0.148) 0.96 x2.47 (x7.83 to 2.90) 0.36 0.000 (x0.004 to 0.004) 0.96
BMI 0.006 (x0.012 to 0.023) 0.56 x0.053 (x0.702 to 0.595) 0.87 0.000 (0.000 to 0.001) 0.82
GRACE risk score 0.001 (x0.004 to 0.005) 0.78 0.074 (x0.076 to 0.223) 0.33 0.000 (0.000 to 0.000) 0.84
Days in hospital 0.043 (x0.090 to 0.175) 0.53 0.826 (x3.87 to 5.52) 0.73 0.000 (x0.004 to 0.004) 0.91
Statin medicatione x0.356 (x0.681 tox0.031) 0.032 x14.08 (x23.13 tox5.03) 0.003 x0.007 (x0.017 to 0.002) 0.12
Antiplatelet medicatione x0.336 (x1.135 to 0.463) 0.41 11.94 (x9.44 to 33.33) 0.55 x0.009 (x0.032 to 0.014) 0.44
Depression (BDI score) x0.004 (x0.018 to 0.009) 0.51 x0.191 (x0.826 to 0.444) 0.55 0.000 (0.000 to 0.000) 0.45
History of depressionf 0.192 (0.040 to 0.345) 0.014 1.06 (x4.17 to 6.29) 0.69 0.000 (x0.004 to 0.005) 0.92
Time of waking x0.005 (x0.041 to 0.031) 0.80
B, Regression coeﬃcient ; CI, conﬁdence interval ; BMI, body mass index ; GRACE, Global Registry of Acute Cardiac Events ; BDI, Beck
Depression Inventory.
Reference groups are : a men ; b white ; c married ; d non-smokers ; e no medication ; f no history of depression.
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Fig. 2.Mean salivary cortisol at six sampling points over
the day in patients with (solid line, diamond) and without
(broken line, disc) a history of depression. Values are
adjusted for age, gender, marital status, ethnicity, smoking
status, body mass index (BMI), Global Registry of Acute
Cardiac Events (GRACE) risk score, days in hospital,
medication with statins and antiplatelet compounds, and
current Beck Depression Inventory (BDI) score.
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Some further limitations of this study should be
considered. Saliva samples were collected over a
single day, and more robust eﬀects may emerge with
repeated sampling. There was no objective measure of
sample timing, so we were reliant on patient reports
for this information. History of depression was col-
lected retrospectively following ACS, and this may
have inﬂuenced reporting patterns, particularly
among patients who were currently depressed. The
study was not powered to determine whether the dif-
ferences in HPA regulation associated with history of
or current depression predicted later cardiac health.
We were also not able to analyse the associations be-
tween cortisol and the combination of elevated de-
pressed mood or depression diagnosis following ACS
and history of depression. The strengths of the study
include the use of a standard interview-based method
of assessing history of depression and current de-
pressive status. We also assessed medication in detail
and controlled for the severity of the cardiac event
with a well-validated measure. Our ﬁndings suggest
that history of depression rather than depressed
mood following ACS is a determinant of overall cor-
tisol output following ACS, whereas current mental
state may be more signiﬁcant to cortisol levels early
in the day. Whether these disturbances of cortisol
regulation are suﬃciently great to mediate in part
the association between post-ACS depression and
future cardiac morbidity will require a more extended
longitudinal study.
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